Comparison of the Safety and Effectiveness of Apixaban versus Warfarin in Patients with Severe Renal Impairment

ConclusionApixaban appears to be a reasonable alternative to warfarin in patients with severe renal impairment.This article is protected by copyright. All rights reserved.

http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fphar.1905

Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - December 31, 2016 Category: Drugs & Pharmacology Authors: Brooke E. Stanton, Naomi S. Barasch, Katie B. Tellor Tags: Original Research Article Source Type: research

More News: Bleeding | Clinical Trials | Coumadin | Dialysis | Drugs & Pharmacology | Hemodialysis | Ischemic Stroke | Peritoneal Dialysis | Stroke | Study | Thrombosis | Warfarin